Pfizer Covid-19 Vaccine | Page 4 | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
June 24, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, JUNE 24, 2025

Pfizer Covid-19 Vaccine

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Full US approval for Pfizer vaccine expected by early September: Report

The vaccine is currently being administered via an emergency use authorization that was granted in December

The company said that it was interested in working exclusively with the government. Photo: Reuters
Coronavirus chronicle

Pfizer and Moderna raises prices for its Covid-19 vaccines in EU

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Covid-19 in Bangladesh

Pfizer says third dose of Covid-19 vaccine boosts protection against Delta variant

Vials with Pfizer-BioNTech and AstraZeneca coronavirus disease (Covid-19) vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Pfizer, Astrazeneca vaccine antibody levels may decline in 2-3 months: Lancet study

Vials with Pfizer-BioNTech and AstraZeneca coronavirus disease (Covid-19) vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Mixed AstraZeneca-Pfizer shot boosts Covid antibody level - study

A vial of the Pfizer vaccine against the coronavirus disease (Covid-19) is seen as medical staff are vaccinated at Sheba Medical Center in Ramat Gan, Israel December 19, 2020. REUTERS/Amir Cohen/File Photo
Coronavirus chronicle

Spacing Pfizer Covid shots boosts antibody levels after initial drop - study

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Analysis

Pfizer/BioNTech bid for booster doses premature, more data needed

A vial of the Pfizer vaccine against the coronavirus disease (Covid-19) is seen as medical staff are vaccinated at Sheba Medical Center in Ramat Gan, Israel December 19, 2020. REUTERS/Amir Cohen/File Photo
Coronavirus chronicle

Pfizer to seek US authorisation for Covid booster shot

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Israel negotiating Pfizer surplus with other countries, official says

The company said that it was interested in working exclusively with the government. Photo: Reuters
Coronavirus chronicle

Pfizer and Moderna vaccines could offer protection for years, study finds

Pfizer says it will have 15m doses of its vaccine ready for people in the US by the end of the year, if it is approved. Photo: Reuters
Coronavirus chronicle

US FDA to add warning about rare heart inflammation to Pfizer, Moderna vaccines

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Pfizer says Covid vaccine highly effective against Delta variant

AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. Picture taken March 16, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Astrazeneca, Pfizer vaccines effective against delta Covid variants: Oxford study

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net